Shares of Sernova Corp. (TSE:SVA – Get Free Report) rose 21.4% during trading on Wednesday . The company traded as high as C$0.17 and last traded at C$0.17. Approximately 276,608 shares changed hands during mid-day trading, an increase of 136% from the average daily volume of 117,275 shares. The stock had previously closed at C$0.14.
Sernova Stock Performance
The company has a current ratio of 0.14, a quick ratio of 18.11 and a debt-to-equity ratio of -25.45. The company has a market cap of C$61.45 million, a PE ratio of -4.25 and a beta of -0.34. The firm’s 50-day simple moving average is C$0.16 and its two-hundred day simple moving average is C$0.15.
About Sernova
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.
Further Reading
- Five stocks we like better than Sernova
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
- Insiders Are Selling These 3 Stocks—Should Investors Be Concerned?
- After SpaceX, Amazon Could Be The Next Best Space Stock
- 3 Stocks to Watch If the Strait of Hormuz Reopens
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
